Atox Bio

Developer of immunomodulators for treatment of rare disease

placeChapel Hill, North Carolina, United States calendar_todayFounded 2003 groups6 employees language atoxbio.com

Registered entities

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 168 times.

YearFilings
20131
20141
20151
20162
20172
20181
20192
20202
20211
20222

Investor mix

10 investors on record; lead investors include Arix Bioscience, SR One, Esperante.

Investor typeCountShare
Venture capital660%
Private equity220%
Bank & private debt110%
Other / undisclosed110%
Coming soon